戻る Agenda
S32 : Optimizing Clinical Trials: Rethinking the “Norms” of Clinical Operations in Japan - Past Assumptions and Future Directions
Session Chair(s)
Kazuyoshi Nanjou
Associate Director
Takeda Pharmaceutical Company Limited., Japan
Speaker(s)
Kazuhiko Mori, PhD, MSc
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Former Executive Director
Kaori Watanabe, MPharm
The University of Tokyo Hospital, Japan
CRC, Clinical Research Promotion Center
Yoko Kurose, MPharm
Pfizer R&D Japan, Japan
Senior Manager, Monitoring Group,Clinical Operations, Development Japan